Are we there yet? The holy grail: A biomarker for Multiple Sclerosis.

Lechner-Scott, Jeannette; Maltby, Vicki; Giovannoni, Gavin; Hawkes, Chris; Levy, Michael; Yeh, Ann.

Afiliação

Lechner-Scott J; John Hunter Hsopital, Hunter New England Local Health District, Newcastle, Australia; Immune Health Program, Hunter Medical Research Institute, Newcastle, Australia. Electronic address: Jeannette.LechnerScott@health.nsw.gov.au.
Maltby V; John Hunter Hsopital, Hunter New England Local Health District, Newcastle, Australia; Immune Health Program, Hunter Medical Research Institute, Newcastle, Australia.
Giovannoni G; Department of Neurology, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, United Kingdom.
Hawkes C; Department of Neuroimmunology, Queen Mary University of London, United Kingdom.
Levy M; Department of Neuroimmunology, Massachusetts General Hospital, Havard Medical School, Boston, USA.
Yeh A; Department of Paediatrics (Neurology), The Hospital for SickKids, University of Toronto in Ontario, Canada.

Mult Scler Relat Disord ; 78: 104998, 2023 Oct.

Article em En | MEDLINE | ID: mdl-37738709

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article